Pharma Deals Review, Vol 2002, No 30 (2002)

Font Size:  Small  Medium  Large

GeneSoft Licenses Rights to Factive from LG Life Sciences

Business Review Editor

Abstract


GeneSoft and LG Life Sciences entered into a licensing agreement for LG’s quinolone antibiotic, Factive® (Gemifloxacin mesylate) for the treatment of bacterial infections.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.